MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 249 filers reported holding MIRATI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,420,109 | -58.7% | 1,364,098 | -65.7% | 0.91% | -56.2% |
| Q2 2023 | $143,725,140 | +4.7% | 3,978,000 | +7.7% | 2.08% | +5.2% |
| Q1 2023 | $137,268,560 | -13.1% | 3,692,000 | +5.8% | 1.98% | -28.3% |
| Q4 2022 | $158,041,280 | +19.1% | 3,488,000 | +83.6% | 2.76% | +19.8% |
| Q3 2022 | $132,696,000 | -3.5% | 1,900,000 | -7.2% | 2.30% | -4.0% |
| Q2 2022 | $137,482,000 | +22.6% | 2,048,000 | +50.1% | 2.40% | +10.6% |
| Q1 2022 | $112,148,000 | -8.5% | 1,364,000 | +63.2% | 2.17% | +8.1% |
| Q4 2021 | $122,633,000 | -2.4% | 836,000 | +17.7% | 2.01% | -5.7% |
| Q3 2021 | $125,606,000 | +17.8% | 710,000 | +7.6% | 2.13% | +11.5% |
| Q2 2021 | $106,610,000 | +16.1% | 660,000 | +23.1% | 1.91% | -9.5% |
| Q1 2021 | $91,817,000 | +53.7% | 536,000 | +97.1% | 2.11% | +3.7% |
| Q4 2020 | $59,742,000 | +114.2% | 272,000 | +61.9% | 2.03% | +100.8% |
| Q3 2020 | $27,896,000 | -10.2% | 168,000 | -38.2% | 1.01% | -25.7% |
| Q2 2020 | $31,054,000 | +29.5% | 272,000 | -12.8% | 1.36% | -8.2% |
| Q1 2020 | $23,983,000 | +55.1% | 312,000 | +160.0% | 1.48% | +66.3% |
| Q4 2019 | $15,463,000 | – | 120,000 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |